𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alteration in α-synuclein mRNA expression in Parkinson's disease

✍ Scribed by Ann E. Kingsbury; Susan E. Daniel; Hardev Sangha; Sarah Eisen; Andrew J. Lees; Oliver J.F. Foster

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
355 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

The presynaptic protein alpha-synuclein is considered to play an important role in the pathophysiology of Parkinson's disease (PD). Point mutations in the alpha-synuclein gene have been demonstrated in familial PD and alpha-synuclein is a major component of Lewy bodies, the pathological hallmark of the sporadic disease. It is not clear whether abnormal accumulation of alpha-synuclein is the result of abnormal levels of expression of the gene in neurodegenerative conditions. Expression of alpha-synuclein mRNA was therefore studied in control and PD brain using semiquantitative in situ hybridization. alpha-synuclein was expressed widely and hybridization signal was seen in most cortical regions, hippocampus, cerebellum, and brain stem. There was little mRNA in the striatum and no hybridization signal was detected in glia. High levels of alpha-synuclein mRNA expression in neurons did not seem to be a marker for Lewy body formation. Abundant signal was seen both in regions in which Lewy body deposition occurs commonly in idiopathic PD (PD), such as substantia nigra and frontal and temporal cortex, as well as in less susceptible regions, e.g. visual cortex. Quantitative comparison of mRNA expression in regions of predilection for Lewy body formation showed that mRNA expression was reduced significantly in melanized substantia nigra neurons and frontal cortex neurons in Parkinson's disease. In substantia nigra neurons there seemed to be a negative correlation between cellular mRNA expression and disease duration. These findings are in broad agreement with other studies of the expression of alpha-synuclein mRNA in human brain and suggest that Lewy body formation is unlikely to be the result of overexpression of alpha-synuclein.

📜 SIMILAR VOLUMES

Expression of α-synuclein mRNA in Parkin
Expression of α-synuclein mRNA in Parkinson's disease
✍ Spiridon Papapetropoulos; Nikhil Adi; Deborah C. Mash; Lina Shehadeh; Nanette Bi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

The letter by Papapetropoulos and colleagues presents an additional study correlating ␣-synuclein expression levels and sporadic PD. Previously we and others published studies of mRNA levels of SNCA in PD brains that have been performed using different methods. Some are in agreement with our results

Alpha-synuclein mRNA expression in spora
Alpha-synuclein mRNA expression in sporadic Parkinson's disease
✍ Eng-King Tan; Van R. Chandran; Stephanie Fook-Chong; Hui Shen; Kenneth Yew; Mei- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract The expression of α‐synuclein gene can be influenced by the genomic load and/or epigenetic factors. By using quantitative real‐time polymerase chain reaction techniques, we demonstrated that the α‐synuclein gene mRNA expression in sporadic PD did not differ from healthy controls (median

Parkinson's disease and α-synuclein expr
Parkinson's disease and α-synuclein expression
✍ Michael J. Devine; Katrina Gwinn; Andrew Singleton; John Hardy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract Genetic studies of Parkinson's disease over the last decade or more have revolutionized our understanding of this condition. α‐Synuclein was the first gene to be linked to Parkinson's disease, and is arguably the most important: the protein is the principal constituent of Lewy bodies, a

Levels of alpha-synuclein mRNA in sporad
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients
✍ Ornit Chiba-Falek; Grisel J. Lopez; Robert L. Nussbaum 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Lewy bodies, the pathological hallmark of Parkinson's disease (PD), consist largely of α‐synuclein, a 14.5‐kDa presynaptic neuronal protein implicated in familial PD. An increased copy number and elevated expression of wild‐type α‐synuclein (__SNCA__) has been shown to cause early‐onset